Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs Ticagrelor in CYP2C19 LOF Carriers Undergoing PCI
NCT02065479Phase 4Completed
- Sponsor
- University of Florida
- Start
- Mar 2014
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prasugrel, ticagrelor in coronary artery disease (CAD), sponsored by University of Florida. Started Mar 2014; status: completed.
02
Drugs
prasugrelticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02065479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065479.